An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).
暂无分享，去创建一个
M. Haider | C. Moulton | S. Gallinger | M. Levine | L. Ruo | K. Gulenchyn | J. Julian | P. Greig | S. Hanna | C. Law | A. Hendler | C. Gu | V. Tandan | T. Finch | M. Marcaccio | R. Hart | D. Jalink | D. Quan | R. Fairfull Smith | M. Husien